Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Pharmaceutics|September 29, 2009
Pluripotent stem cells as new drugs? The example of Parkinson's diseaseOlivier Preynat-Seauve, Pierre R Burkhard, Jean Villard, et al.
Frontiers in Pharmacology|May 14, 2023
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)François R Girardin, Anna Nicolet, Oriol Bestard, et al.
Frontiers in Immunology|April 7, 2023
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantationCassandra Ballou, Franca Barton, Elizabeth H Payne, et al.
Frontiers in Immunology|March 6, 2023
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort StudyOlivier de Rougemont, Yun Deng, Lukas Frischknecht, et al.
Frontiers in Immunology|February 16, 2024
Pre-transplant donor specific antibodies in ABO incompatible kidney transplantation - data from the Swiss transplant cohort studyYun Deng, Lukas Frischnknecht, Caroline Wehmeier, et al.
Revue Medicale Suisse|March 6, 2023
[Collaboration in nephrology between Geneva and Yaoundé: a convincing example]Patrick Saudan, James Tataw, Fadi Haidar, et al.
Frontiers in Immunology|October 10, 2022
The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation - Data from the Swiss transplant cohort studyLukas Frischknecht, Yun Deng, Caroline Wehmeier, et al.
Pageof 11